ResearcherAnhui Medical UniversityNo recent work listed
Xiansheng Lin
Matched on OpenAlex author ID A5113559718. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine. Co-author DOI 10.1038/s41598-023-48298-9↗
- Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.3233/cbm-190908↗
- The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine. Co-author DOI 10.1038/s41598-018-26496-0↗
- Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein. Co-author DOI 10.18632/oncotarget.11780↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fang Xie · 4 shared papers, 2016–2023 · strength 0.47
- Paper Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances t… DOI 10.1038/s41598-023-48298-9↗
- Paper Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating EZH2 in pancreatic… DOI 10.3233/cbm-190908↗
- Paper The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic ef… DOI 10.1038/s41598-018-26496-0↗
- Qiang Huang · 3 shared papers, 2016–2023 · strength 0.35
- Paper Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances t… DOI 10.1038/s41598-023-48298-9↗
- Paper The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic ef… DOI 10.1038/s41598-018-26496-0↗
- Paper Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein. DOI 10.18632/oncotarget.11780↗
- Zhen Liu · 2 shared papers, 2018–2023 · strength 0.28
- Paper Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances t… DOI 10.1038/s41598-023-48298-9↗
- Paper The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic ef… DOI 10.1038/s41598-018-26496-0↗
- Cheng Wang · 1 shared paper, 2020 · strength 0.12
- Chao Wang · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.